75F40120C00172

BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	FDA OFFICE OF ACQ GRANT SVCS
NAICS	541990 — All Other Professional, Scientific, and Technical Services
PSC	AN41 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$1.4M
Current contract value	$1.4M
Potential contract value / ceiling	$1.4M
Start date	Sep 28, 2020
Current end date	Jan 11, 2024
Potential end date	Jan 11, 2024
Latest award activity	Jul 23, 2026
Source loaded	Sep 26, 2026

Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jul 23, 2026	P00006	$-185.0K	DEOBLIGATION/CLOSEOUT
Feb 28, 2023	P00005	$0	BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)
Jan 11, 2023	P00004	$533.9K	BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)
Sep 7, 2022	P00003	$0	BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)
Dec 13, 2021	P00002	$0	BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)
Jul 7, 2021	P00001	$517.3K	BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)
Sep 28, 2020	0	$562.5K	BAA: EVALUATION OF CURRENT APPROACHES USED TO ESTABLISH BIOEQUIVALENCE OF NASAL SPRAYS FOR LOCAL ACTION IN CHILDREN (PMQWP 253)